Editorial: SARS-CoV-2 in neurodegenerative diseases

Front Neurosci. 2024 Jan 16:18:1360234. doi: 10.3389/fnins.2024.1360234. eCollection 2024.

Authors

Gonzalo Emiliano Aranda-Abreu¹, Alfonso Carreón-Rodriguez², Sonia Zuñiga³, David Pozo⁴

Affiliations

¹ Instituto de Investigaciones Cerebrales, Universidad Veracruzana, Xalapa, Mexico.
² Instituto Nacional de Salud Pública, Cuernavaca, Morelos, Mexico.
³ National Center for Biotechnology, Spanish National Research Council (CSIC), Madrid, Spain.
⁴ Department of Medical Biochemistry, Molecular Biology and Immunology, Faculty of Medicine, University of Seville, Seville, Spain.

No abstract available

Keywords: SARS-CoV-2; brain; disease; neurodegeneration; neuroinflammation.

Publication types

Editorial

Grants and funding

The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.